Archives for October 22, 2013

Amarin supplier continues production of Omega-3s following US FDA panel decision

Omega-3 supplier BASF will continue to produce the API for Amarin, as well as its competitor GlaxoSmithKline, despite an FDA panel saying that Amarin’s drug should not be approved for a broader population.

Mylan Labs, Natco Pharma look to expand injectable manufacturing, CEOs say

Indian manufacturing heavyweight Mylan Laboratories is looking to build off its major acquisition of Agila with a number of smaller acquisitions, while Natco is about to receive a cash infusion for manufacturing expansions.

Ben Venue closure: Company evaluates facility, EMA evaluates shortages

Ben Venue’s closure is still being evaluated the troubled drugmaker says, in the week the European Medicines Agency (EMA) is meeting to discuss ongoing shortages.

Dispatches from CPhI

McKinsey consultants help to pull Patheon off the road to bankruptcy

Patheon brought in McKinsey consultants over the last three years to help overhaul its sagging business and institute a number of simple process changes that resulted in deep transformations.

DISPATCHES FROM CPhI

Catalent launches softgel products at CPhI: one vegetarian, one anti-abuse

Catalent has announced two new softgel solutions as it adds greater versatility to its Advanced Technologies Business Unit.